Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
VAK / Wuhan Binhui Biotech
NCT05565014: Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion	Recruiting	1	90	RoW	Virus Activated Killer immune Cells, VAK, Saline	Sheng Hu, Wuhan Binhui Biotechnology Co., Ltd.	Malignant Pleural Effusion, Malignant Peritoneal Effusion	12/23	06/24